Senju Pharmaceutical Co. Ltd. v. Aurobindo Pharma Ltd.
1:14-cv-00579
Overview
Parties
Defendant
Aurobindo Pharma USA Inc. Operating Company
Represented By
1 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Aurobindo Pharma Ltd. Operating Company
Represented By
4 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Morris James LLP
500 Delaware Avenue, Suite 1500, P.O. Box 2306
Plaintiff
Kyorin Pharmaceutical Co. Ltd. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Senju Pharmaceutical Co. Ltd. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Allergan Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 6,333,045 Asserted | Asserted Patent | View Official Patent → |
| π―π΅ Japan | JP 23543298 | Japan Counterpart | View Official Patent → |
| π PCT International (WIPO) | WO 2000010570 A1 | PCT World Application | View Official Patent → |
Senju Pharmaceutical Co. Ltd. v. Actavis Inc.
Senju Pharmaceutical Co. Ltd. v. Lupin Limited
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6333045
Aqueous liquid pharmaceutical composition comprised of gatifloxacin
|
Filed: 1999-08-20
Issued: 2001-12-25
|
Expired (Term Ended)
Expires: 2019-08-20
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
5
Dispositive
4
Granted
2
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings